0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

From
EUR$4,750USDGBP
From
EUR$2,349USDGBP
From
EUR$7,500USDGBP
From
EUR$3,995USDGBP
Collaboration Deals in Pharmaceuticals 2019-2025 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2025

  • Report
  • April 2025
  • 950 Pages
  • Global
From
EUR$3,995USDGBP
Dermatological Drugs Market Report 2024-2034 - Product Thumbnail Image

Dermatological Drugs Market Report 2024-2034

  • Report
  • February 2024
  • 280 Pages
  • Global
From
EUR$6,070USDGBP
From
EUR$4,949USDGBP
Loading Indicator
This website uses cookies to ensure you get the best experience. Learn more